Skip to main content
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.200
+0.360 (9.38%)
At close: Apr 28, 2026, 4:00 PM EDT
4.210
+0.010 (0.24%)
Pre-market: Apr 29, 2026, 7:01 AM EDT

IMDX Revenue

In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.05M with 115.58% growth. Insight Molecular Diagnostics had revenue of $1.14M in the quarter ending December 31, 2025, a decrease of -23.35%.

Revenue (ttm)
$4.05M
Revenue Growth
+115.58%
P/S Ratio
33.32
Revenue / Employee
$69,914
Employees
58
Market Cap
135.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.05M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 824.50M
Castle Biosciences 344.23M
Fulgent Genetics 322.67M
MDxHealth 107.88M
FONAR 106.03M
Prenetics Global 92.39M
Biodesix 88.50M
Burning Rock Biotech 77.14M
Revenue Rankings

IMDX News

More News